NEW DELHI: The screening of youngsters aged 6 to 12 years for the scientific trials of indigenously developed Covid-19 vaccine, Bharat Biotech’s Covaxin is scheduled to begin from Tuesday.
In keeping with sources, the recruitment for scientific trials of Covaxin amongst these aged 12 to 18 years is over. They’ve been given a single dose of vaccine.
After the recruitment of youngsters aged 6-12 years, AIIMS-Delhi will probably be conducting trials for the 2-6 age group. The paths are going down at 525 centres.
AIIMS Patna, Mysore Medical Faculty and Analysis Institute in Karnataka have additionally been chosen to conduct scientific trials on youngsters.
“We’ve began recruitment for youngsters aged 6-12 years. Recruitments for scientific trials on youngsters aged 12-18 years is over. They are going to be stored underneath statement.” stated Prabhat Kumar Singh, director, AIIMS, Patna.